Medindia

X

Hepatitis C Patients Say Cutbacks Block Vital Drugs

by Bidita Debnath on  December 27, 2014 at 11:52 PM Drug News   - G J E 4
A lot of hepatitis C sufferers and their supporters protested in Madrid, complaining that public spending cuts were cutting off access to a drug that could cure the deadly liver illness.
Hepatitis C Patients Say Cutbacks Block Vital Drugs
Hepatitis C Patients Say Cutbacks Block Vital Drugs
Advertisement

People infected with the virus have been occupying the October 12 Hospital in southern Madrid for a week demanding the government authorise doctors to prescribe the drug more widely.

Advertisement
On Saturday several hundred patients and their backers, yelling and waving banners, took their protest to the gate of the health ministry, which they accuse of not spending enough to make the drugs available to all who need them.

"If they do not give us the latest generation medicines, we will die," said one sufferer, Antonio Fernandez, 59, at the demo by the Platform for Hepatitis C Sufferers.

The group says 12 people die each day from hepatitis C in Spain, where it estimates hundreds of thousands of people are infected.

The new hepatitis drug sofosbuvir -- marketed under the brand Sovaldi -- was approved for use in Spain in November but the group says the authorities have only spent enough to provide the drug for about 5,000 patients.

"It is trickling through," Fernandez said.

There is currently no vaccine for hepatitis C, which is caused by a virus that can be caught from contaminated blood and can lead to chronic liver disease.

A spokeswoman for Spain's health ministry told AFP that prescribing the drug depended on clinical criteria, not on budgets.

The ministry said in a statement on December 23 it was consulting experts "to ensure access for patients to the treatments they need in line with clinical criteria".

But the protest group accused officials of blocking access to sofosbuvir to save money.

"This is a very serious problem with a very simple solution. It is an economic matter," Fernandez said.

The drug has a 95 percent success rate, according to the group, but it reportedly costs tens of thousands of euros per patient.

Spain's conservative government has made tough public spending cuts in health and other sectors to stabilise the public finances in the recent economic crisis.

Spain's overall national health spending declined from 70 billion euros ($88 million) in 2009 to about 53 billion euros in 2014, according to government figures.

Source: AFP
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All